发明名称 GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE
摘要 The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives, and fragments thereof as well as compositions and kits comprising them. Further provided are methods of using glycan-interacting antibodies to target cells and treat disease.
申请公布号 US2016130356(A1) 申请公布日期 2016.05.12
申请号 US201614987432 申请日期 2016.01.04
申请人 Siamab Therapeutics, Inc. 发明人 DeSander Julie;Behrens Jeffrey
分类号 C07K16/30;A61K39/395;A61K47/02;A61K47/48;A61K47/12 主分类号 C07K16/30
代理机构 代理人
主权项 1. A method of reducing tumor volume comprising administering an antibody to a subject in need thereof, wherein said antibody is administered at a dose of from about 0.25 mg/kg to about 25 mg/kg and wherein said antibody comprises a variable domain having an amino acid sequence comprising at least 95% amino acid sequence identity to an amino acid sequence selected from the group consisting of SEQ ID NOs: 15-52.
地址 Newton MA US